Funded Tech Companies
Synthekine
Synthekine, based in Menlo Park, received equity investments from The Column Group, Lilly Asia Ventures and Deerfield Capital.
Company Overview
Company Name
Synthekine
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1505 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific, selective and potent cytokine therapies. Our targeted protein engineering guided by our deep experience in immunology provides transformative immunotherapies for the treatment of cancer and autoimmune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/6/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Debanjan Ray
Chief Medical Officer
Naiyer Rizvi
Vice President
Richard Murphy
Vice President
Gregory Yedinak
VP - Bus. Development
Martin Oft
VP - Finance
Robin Knifsend
VP - Operations
Christine Rocha
VP - R & D
Robert Kastelein
VP - R & D
Patrick Lupardus
Company Investors
- The Column Group (Timothy Kutzkey)
- Lilly Asia Ventures
- Deerfield Capital
- Omega Funds
- Canaan Partners (Julie Grant)
- Rock Springs Capital
- TCG Crossover
- Samsara BioCapital (Srinivas Akkaraju)
- RA Capital
- Janus Henderson Investors
- Emerson Collective
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs